MedPath

Modelling Internal Hepatic Movement With an External Abdominal Marker

Conditions
Patients With Liver Metastases From Colorectal Cancer
Registration Number
NCT00299299
Lead Sponsor
Royal Marsden NHS Foundation Trust
Brief Summary

This study tests the feasibility and reproducibility of patient-specific motion models. These will be used for quantification of safe margin reduction. Patient-specific motion models will be built by post-processing 4D MRI data with non-rigid registration. By comparing these models between visits, model reproducibility will be assessed, and the methodology refined.

Detailed Description

The study will use a real time position management (RPM) system for respiratory gating. The RPM system senses the respiration motion of the patient by tracking a pair of reflective markers on a lightweight "marker block" constructed of a synthetic material. This block is placed on the patient's abdomen.

During Radiotherapy, the beam is only switched on at pre-determined phases of respiration. The appropriate phase of respiration is determined by the RPM system. This implies a reliable correlation of external block motion to internal hepatic movement. This correlation is not a simple one, and requires "modeling".

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Histologically confirmed adenocarcinoma compatible with primary disease in the colon or rectum
  • Aged 18 years or older
  • Unequivocal contrast-enhanced CT and/or MRI evidence of malignant single or multiple metastases in the liver, metastases at other sites will not be an exclusion criterion
  • WHO performance status 0-2 and life expectancy of at least 12 weeks
  • Informed written consent
Exclusion Criteria
  • Pregnancy or breast feeding
  • Evidence of ascites
  • Patients unable for whatever reason to lie flat
  • Patients unable to give fully informed consent
  • Age< 18 years

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Royal Marsden Hospital

🇬🇧

Chelsea, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath